ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 72 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,541 | -20.2% | 598 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $4,438 | -21.5% | 598 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $5,652 | -11.3% | 598 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $6,369 | +59.2% | 598 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $4,000 | +33.3% | 598 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,000 | 0.0% | 598 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,000 | -25.0% | 598 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $4,000 | -20.0% | 598 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $5,000 | 0.0% | 598 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $5,000 | 0.0% | 598 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | 0.0% | 598 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | -16.7% | 598 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $6,000 | – | 598 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 90,000 | $702,000 | 0.41% |
| Rubric Capital Management LP | 294,683 | $2,299,000 | 0.17% |
| Interchange Capital Partners, LLC | 24,420 | $190,000 | 0.10% |
| GOODWIN DANIEL L | 20,000 | $156,000 | 0.09% |
| Consonance Capital Management LP | 88,428 | $690,000 | 0.06% |
| DCM Advisors, LLC | 13,300 | $104,000 | 0.06% |
| Virtu Financial LLC | 27,524 | $215,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 68,899 | $537,000 | 0.01% |
| Lindbrook Capital, LLC | 1,000 | $8,000 | 0.00% |
| ExodusPoint Capital Management, LP | 11,900 | $93,000 | 0.00% |